# A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma

> **NCT05527275** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 78 (estimated)

## Conditions studied

- Relapsed and Refractory Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** Mitoxantrone liposome combine with Chidamide

## Key facts

- **NCT ID:** NCT05527275
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527275, "A Phase I/II Study of Mitoxantrone Liposome Combined With Chidamide in Relapsed/Refractory Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05527275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*